Gestational diabetes mellitus: risks and management during and after pregnancy

被引:573
作者
Buchanan, Thomas A. [1 ]
Xiang, Anny H. [2 ]
Page, Kathleen A. [1 ]
机构
[1] Univ So Calif, Div Endocrinol & Diabet, Dept Med, Keck Sch Med, Los Angeles, CA 90033 USA
[2] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA
关键词
IMPAIRED GLUCOSE-TOLERANCE; ISLET-CELL ANTIBODIES; INTRAUTERINE EXPOSURE; INSULIN-RESISTANCE; HISPANIC WOMEN; FETAL ULTRASOUND; FASTING GLUCOSE; BIRTH-WEIGHT; LATINO WOMEN; TYPE-2;
D O I
10.1038/nrendo.2012.96
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Gestational diabetes mellitus (GDM) carries a small but potentially important risk of adverse perinatal outcomes and a long-term risk of obesity and glucose intolerance in offspring. Mothers with GDM have an excess of hypertensive disorders during pregnancy and a high risk of developing diabetes mellitus thereafter. Diagnosing and treating GDM can reduce perinatal complications, but only a small fraction of pregnancies benefit. Nutritional management is the cornerstone of treatment; insulin, glyburide and metformin can be used to intensify treatment. Fetal measurements complement maternal glucose monitoring in the identification of pregnancies that require such intensification. Glucose testing shortly after delivery can stratify the short-term diabetes risk in mothers. Thereafter, annual glucose and HbA(1c) testing can detect deteriorating glycaemic control, a harbinger of future diabetes mellitus, usually type 2 diabetes mellitus. Interventions that mitigate obesity or its metabolic effects are most potent in preventing or delaying diabetes mellitus. Lifestyle modification is the primary approach; use of medications for diabetes prevention after GDM remains controversial. Family planning enables optimization of health in subsequent pregnancies. Breastfeeding may reduce obesity in children and is recommended. Families should be encouraged to help children adopt lifestyles that reduce the risk of obesity.
引用
收藏
页码:639 / 649
页数:11
相关论文
共 80 条
[2]
[Anonymous], CAN GUID CLIN PREV H
[3]
Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J].
Buchanan, TA ;
Xiang, AH ;
Peters, RK ;
Kjos, SL ;
Marroquin, A ;
Goico, J ;
Ochoa, C ;
Tan, S ;
Berkowitz, K ;
Hodis, HN ;
Azen, SP .
DIABETES, 2002, 51 (09) :2796-2803
[4]
USE OF FETAL ULTRASOUND TO SELECT METABOLIC THERAPY FOR PREGNANCIES COMPLICATED BY MILD GESTATIONAL DIABETES [J].
BUCHANAN, TA ;
KJOS, SL ;
MONTORO, MN ;
WU, PYK ;
MADRILEJO, NG ;
GONZALEZ, M ;
NUNEZ, V ;
PANTOJA, PM ;
XIANG, A .
DIABETES CARE, 1994, 17 (04) :275-283
[5]
What is gestational diabetes? [J].
Buchanan, Thomas A. ;
Xiang, Anny ;
Kjos, Sim L. ;
Watanabe, Richard .
DIABETES CARE, 2007, 30 :S105-S111
[6]
(How) can we prevent type 2 diabetes? [J].
Buchanan, Thomas A. .
DIABETES, 2007, 56 (06) :1502-1507
[7]
EXERCISE IN GESTATIONAL DIABETES - AN OPTIONAL THERAPEUTIC APPROACH [J].
BUNG, P ;
ARTAL, R ;
KHODIGUIAN, N ;
KJOS, S .
DIABETES, 1991, 40 :182-185
[8]
Calonge N, 2008, ANN INTERN MED, V148, P759
[9]
Perinatal risk factors for childhood obesity and metabolic dysregulation [J].
Catalano, Patrick M. ;
Farrell, Kristen ;
Thomas, Alicia ;
Huston-Presley, Larraine ;
Mencin, Patricia ;
de Mouzon, Sylvie Hauguel ;
Amini, Saeid B. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2009, 90 (05) :1303-1313
[10]
INCIDENCE AND SIGNIFICANCE OF ISLET CELL ANTIBODIES IN WOMEN WITH PREVIOUS GESTATIONAL DIABETES [J].
CATALANO, PM ;
TYZBIR, ED ;
SIMS, EAH .
DIABETES CARE, 1990, 13 (05) :478-482